Schedule 13G ownership disclosure
TriSalus Life Sciences Inc
Common Stock · CUSIP: 89680M101
Event date: 2024-12-30
- Filing-level shares
- 0.00
- Percent of class
- 0%
- Lombard International Assurance S.A.
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-002258
- Form type
- SCHEDULE 13G
- Filer
- Lombard International Assurance S.A.
- CIK
- CIK 1767788
- Filed
- Jan 10, 2025
- Reporting period
- Dec 30, 2024
- Description
- Schedule 13G beneficial ownership